The Joslin DRC
Since its founding in 1898, the mission of the Joslin Diabetes Center has been to improve the lives of patients with diabetes through research, clinical care, and education to find new treatments, improve care and prevent disease in those at risk. Over the past 30 years, this research at Joslin has been supported by NIH/NIDDK through a Diabetes Research Center (DRC) Program Grant led by George L. King, MD.
Mission of the DRC at Joslin
- Create an environment that supports world-class investigation in diabetes and metabolism.
- Sustain and strengthen the diabetes research infrastructure through core laboratories that provide outstanding expertise and cutting edge technologies.
- Catalyze new diabetes research and multidisciplinary collaborations that transform the field of diabetes research through support of early-stage research (Pilot and Feasibility Program) and a comprehensive program of seminars and symposia (Enrichment Program).
- Translate new knowledge to improved care and prevention.
Explore Our DRC Cores
When it comes to diabetes, Joslin is a research powerhouse. Our NIH/NIDDK funded cores provide critical services to keep our research initiatives moving forward.
The purpose of the Animal Physiology Core is to provide technically advanced physiological evaluation of metabolism in diabetes, obesity, and the associated complications in rodents for Joslin Diabetes Research Center investigators and outside users.
Clinical Translational Research Core
The Joslin Clinical Translational Research Center offers a safe, comfortable, and effective environment to conduct outpatient clinical research studies.
The Joslin Flow Cytometry Core provides reliable and affordable cell sorting and flow cytometry services to its users so that they can isolate, analyze, and study cells that increase our understanding of diabetes and its complications, and ultimately, develop treatments and cures for these diseases.
Genome Editing Core
The Genome Editing Core (GEC) provides investigators with resources to manipulate the genome of human cell lines and laboratory mice with the aim of studying genetics underlying diabetes and its complications.
Molecular Phenotyping & Genotyping
The objective of the Molecular Phenotyping and Genotyping Core is to support Joslin and external investigators in the study of molecular mechanisms of disease by providing equipment, expertise, and services in molecular phenotyping.
The Diabetes and Metabolism Research Seminars are held on Thursdays at Noon in the Samuelian Lecture Hall.
Artificial pancreas system better controls blood glucose levels than current technology
Joslin Study Finds Insulin Regulates Beta Cell Function in Healthy Humans
The DRC offers researchers specialized cutting-edge technology assistance as well as a network of colleagues from across the medical and scientific community. Joslin is proud to have been selected as one of only 16 NIDDK-funded DRCs across the country.
George L. King, M.D.
Chief Scientific Officer
Read a message from George L. King, M.D., Chief Scientific Officer, on what sets our diabetes research apart from other institutions.